A detailed history of Chesley Taft & Associates LLC transactions in Viatris Inc stock. As of the latest transaction made, Chesley Taft & Associates LLC holds 10,410 shares of VTRS stock, worth $135,330. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,410
Previous 10,544 1.27%
Holding current value
$135,330
Previous $112,000 7.14%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$10.32 - $12.13 $1,382 - $1,625
-134 Reduced 1.27%
10,410 $120,000
Q2 2024

Jul 19, 2024

SELL
$10.05 - $12.02 $55,094 - $65,893
-5,482 Reduced 34.21%
10,544 $112,000
Q1 2024

Apr 15, 2024

SELL
$11.27 - $13.53 $710 - $852
-63 Reduced 0.39%
16,026 $191,000
Q4 2023

Jan 11, 2024

SELL
$8.77 - $10.85 $2,499 - $3,092
-285 Reduced 1.74%
16,089 $174,000
Q3 2023

Oct 10, 2023

SELL
$9.59 - $11.35 $2,589 - $3,064
-270 Reduced 1.62%
16,374 $161,000
Q2 2023

Jul 17, 2023

SELL
$9.02 - $10.29 $1,109 - $1,265
-123 Reduced 0.73%
16,644 $166,000
Q1 2023

Apr 11, 2023

SELL
$9.2 - $12.26 $763 - $1,017
-83 Reduced 0.49%
16,767 $161,000
Q4 2022

Jan 19, 2023

SELL
$8.72 - $11.56 $1,752 - $2,323
-201 Reduced 1.18%
16,850 $0
Q3 2022

Oct 13, 2022

SELL
$8.48 - $11.13 $1,823 - $2,392
-215 Reduced 1.25%
17,051 $145,000
Q2 2022

Jul 07, 2022

SELL
$9.95 - $12.27 $19,362 - $23,877
-1,946 Reduced 10.13%
17,266 $181,000
Q1 2022

Apr 14, 2022

SELL
$9.81 - $15.4 $4,816 - $7,561
-491 Reduced 2.49%
19,212 $205,000
Q4 2021

Jan 05, 2022

SELL
$12.09 - $14.68 $26,017 - $31,591
-2,152 Reduced 9.85%
19,703 $267,000
Q3 2021

Oct 05, 2021

SELL
$13.25 - $15.13 $821 - $938
-62 Reduced 0.28%
21,855 $296,000
Q2 2021

Jul 07, 2021

SELL
$12.97 - $16.15 $18,962 - $23,611
-1,462 Reduced 6.25%
21,917 $313,000
Q1 2021

Apr 06, 2021

SELL
$13.59 - $18.54 $53,218 - $72,602
-3,916 Reduced 14.35%
23,379 $328,000
Q4 2020

Jan 11, 2021

BUY
$14.3 - $18.74 $390,318 - $511,508
27,295 New
27,295 $512,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Chesley Taft & Associates LLC Portfolio

Follow Chesley Taft & Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesley Taft & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chesley Taft & Associates LLC with notifications on news.